ArticleOncogene2026

Development and preclinical evaluation of a decoy DLL4-encoding oncolytic HSV-1 for high-grade glioma.

Kimberly A Rivera-Caraballo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.